Abstract:Summary Background Gout, a common crystal arthropathy, is associated with increased risk of cardiovascular disease. We aimed to identify how this risk varies by individual cardiovascular disease across a broad spectrum of conditions. Methods In this matched case–control study, we used linked primary and secondary electronic health records from the UK Clinical Practice Research Datalink to assemble a cohort of individuals with a first-time diagnosis of gout between Jan 1, 2000 and Dec 31, 2017, who were aged 80 years or younger at diagnosis, and free of cardiovascular diseases up to 12 months after diagnosis. The control cohort comprised up to five control individuals per patient with gout, matched on age, sex, socioeconomic status, geographical region, and calendar time, randomly selected among individuals free of gout at any time before and during the study period. The cohorts were followed up until June 30, 2019. We investigated the incidence of 12 cardiovascular diseases and used Cox proportional hazards models to examine differences in people with and without gout, overall and by subgroups of sex, age, socioeconomic status, and year of study inclusion. We further adjusted models for known cardiovascular risk factors (blood pressure, BMI, smoking status, cholesterol, type 2 diabetes, chronic kidney disease, and history of hypertension). Findings We identified 152 663 individuals with gout (mean age 56·2 years [SD 13·3]; 120 324 [78·8%] men and 32 339 [21·2%] women) and 709 981 matched controls (mean age 56·5 years [13·2]; 561 002 [79·0%] men and 148 979 [21·0%] women). Of these individuals, 31 479 (20·6%) with gout and 106 520 (15·0%) without gout developed cardiovascular disease during a median follow-up of 6·5 years (IQR 3·1–10·5). Patients with gout had higher risk of cardiovascular diseases than matched controls (hazard ratio [HR] 1·58 [95% CI 1·52–1·63]). Excess risk of cardiovascular disease in gout was greater in women than men (women: HR 1·88 [1·75–2·02]; men: HR 1·49 [1·43–1·56]), and, among all age groups, was highest in younger individuals (HR in people aged <45 years: 2·22 [1·92–2·57]). Excess risk was observed across all 12 cardiovascular diseases investigated. Patients with gout had higher BMI than matched controls (mean difference 2·90 kg/m 2 [95% CI 2·87–2·93]) and higher prevalence of chronic kidney disease, dyslipidaemia, history of hypertension, obesity, and type 2 diabetes. Adjusting for known cardiovascular risk factors attenuated but did not eliminate the excess risk of cardiovascular disease related to gout (adjusted HR 1·31 [1·27–1·36]). Interpretation Patients with gout had an excess risk of developing a broad range of cardiovascular diseases that extend beyond atherosclerotic diseases and include heart failure, arrhythmias, valve disease, and thromboembolic diseases. Excess risk was highest in women and younger individuals. These findings suggest that strategies to reduce cardiovascular risk in patients with gout need to evolve and be implemented in clinical practice. Funding Research Foundation Flanders.

Increased Risk of Cancer in relation to Gout: A Review of Three Prospective Cohort Studies with 50,358 Subjects.

Association between gout and cancers: A systematic review and meta-analysis

Hyperuricemia and Gout Are Associated with Cancer Incidence and Mortality: A Meta‐analysis Based on Cohort Studies

All-cause and Specific Mortality in Patients with Gout: A Systematic Review and Meta-Analysis.

Impact of gout on cardiovascular disease mortality: a meta-analysis

Causal relationship between gout and liver cancer: A Mendelian randomization and transcriptome analysis

The Association Between Gout And Cataract Risk: A Meta-Analysis

Gout And The Risk Of Parkinson'S Disease: A Cohort Study

Risk of dementia in gout and hyperuricaemia: a meta-analysis of cohort studies

Risk of incident benign prostatic hyperplasia in patients with gout: a retrospective cohort study

Gout and incidence of 12 cardiovascular diseases: a case–control study including 152 663 individuals with gout and 709 981 matched controls

Gout is Not Associated with the Risk of Fracture: a Meta-Analysis

Gender-specific risk factors for gout: a systematic review of cohort studies

The Effect of Uric Acid Level, Hyperuricemia and Gout on the Risk of Type 2 Diabetes: A Meta-Analysis of Cohort Studies

High Serum Uric Acid May Associate with the Increased Risk of Colorectal Cancer in Females: A Prospective Cohort Study.

Psoriasis, psoriatic arthritis and risk of gout in US men and women.

Risk factors for gout developed from hyperuricemia in China: a five-year prospective cohort study

Gout/hyperuricemia reduces the risk of Alzheimer's disease: A meta‐analysis based on latest evidence

Associations between serum uric acid and hepatobiliary-pancreatic cancer: A cohort study

Effects of dietary factors on hyperuricaemia and gout: a systematic review and meta-analysis of observational studies

Serum Uric Acid Increases Risk of Cancer Incidence and Mortality: A Systematic Review and Meta-Analysis.